5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01652781
Recruitment Status : Unknown
Verified November 2015 by Yoo-Jin Kim, Seoul St. Mary's Hospital.
Recruitment status was:  Recruiting
First Posted : July 30, 2012
Last Update Posted : November 20, 2015
Celgene Corporation
Information provided by (Responsible Party):
Yoo-Jin Kim, Seoul St. Mary's Hospital

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : June 2016
  Estimated Study Completion Date : December 2016